Background: Although disease-specific exercise guidelines for cardiovascular disease (CVD) are widely available, it remains uncertain whether these different exercise guidelines are integrated properly for patients with different CVDs. The aim of this study was to assess the inter-clinician variance in exercise prescription for patients with various CVDs and to compare these prescriptions with recommendations from the EXercise Prescription in Everyday practice and Rehabilitative Training (EXPERT) tool, a digital decision support system for integrated state-of-the-art exercise prescription in CVD. Design: The study was a prospective observational survey. Methods: Fifty-three CV rehabilitation clinicians from nine European countries were asked to prescribe exercise intensity (based on percentage of peak heart rate (HR peak )), frequency, session duration, programme duration and exercise type (endurance or strength training) for the same five patients. Exercise prescriptions were compared between clinicians, and relationships with clinician characteristics were studied. In addition, these exercise prescriptions were compared with recommendations from the EXPERT tool. Results: A large inter-clinician variance was found for prescribed exercise intensity (median (interquartile range (IQR)): 83 (13) % of HR peak ), frequency (median (IQR): 4 (2) days/week), session duration (median (IQR): 45 (18) min/session), programme duration (median (IQR): 12 (18) weeks), total exercise volume (median (IQR): 1215 (1961) peak-effort training hours) and prescription of strength training exercises (prescribed in 78% of all cases). Moreover, clinicians' exercise prescriptions were significantly different from those of the EXPERT tool (p < 0.001).
Introduction
Exercise training leads to significant improvements in exercise capacity, muscle strength and endurance, and quality of life in patients with cardiovascular disease (CVD), thereby reducing cardiovascular (CV) event rates, hospitalizations and mortality. [1] [2] [3] [4] Exercise training is therefore a cornerstone in the multidisciplinary rehabilitation of patients with CVD. 5 Despite the availability of international exercise guidelines for the secondary prevention of CVD, 5-8 a large variance in exercise prescription (exercise type, frequency, volume, intensity, session duration and programme duration) has been found between different CV rehabilitation centres. [9] [10] [11] [12] [13] [14] [15] [16] [17] This may be related to significant differences in the characteristics of patients who enter the rehabilitation programme, or in regulations and/or facilities between these different centres. Most importantly, even though international exercise guidelines have been widely available for decades and should be well known, they are mostly disease-specific. Thus, there are no guidelines on how to integrate different exercise prescriptions for the same patient with different CVDs and risk factors.
Evidence-based (inter)national standardization initiatives for exercise prescription in CV rehabilitation should, if applied appropriately, remediate such variance in exercise prescriptions. It thus remains to be examined whether a single patient with different CVDs and risk factors would receive similar exercise prescriptions from different clinicians in different countries, and whether these exercise prescriptions are in line with clinical guidelines.
This study therefore compared exercise prescriptions generated by clinicians and by the EXercise Prescription in Everyday practice and Rehabilitative Training (EXPERT) tool, 18, 19 which is a digital decision support system for integrated state-of-the-art exercise prescription in CVD. There are no published integrated guidelines that cover different CVD states and risk factors, so in essence the EXPERT tool represents the first attempt to provide such guidelines. This allowed us to determine to what extent exercise prescriptions from clinicians match the prescriptions of the EXPERT tool. We hypothesized that there would be high variance in exercise prescriptions for patients with different CVDs and risk factors between clinicians, and that exercise prescriptions between clinicians and the EXPERT tool would therefore be dissimilar.
Methods

Study design
This was a prospective observational study, approved by a local medical ethical committee (Hasselt University and Jessa Hospital, Hasselt, Belgium), adhering to the standards of the Helsinki declaration. All participants gave consent for the collected data to be used for research purposes. From March 2016 to April 2017, European CV rehabilitation clinicians were requested to formulate exercise training prescriptions for five authentic cases, with proper artificial modulation of CV risk, in order to increase the power of recognition of the model. These anonymized data were analysed for inter-clinician variance in exercise prescription. In addition, these exercise prescriptions were compared with exercise prescriptions from the EXPERT tool.
Participants
Participants included both European Association of Preventive Cardiology (EAPC) EXPERT working group members (invited by the study coordinator by personal invitation) 18, 19 and other individuals who were contacted from within the working group (by personal invitation from EAPC EXPERT working group members): these participants were required to be European citizens actively involved in the prescription and administration of structured CV rehabilitation programmes across different national health systems. Initially, 73 clinicians agreed to participate, but 20 of these did not fill out all five patient cases and were excluded from the analysis. The majority of the remaining 53 clinicians (from Belgium, The Netherlands, Germany, France, the United Kingdom, Italy, Spain, Austria and Portugal) were cardiologists (68%), followed by physiotherapists (11%), CV rehabilitation scientists (7%), physiatrists (6%), and sports physicians, general practitioners, rehabilitation physicians and exercise physiologists (2% in each category). There were no restrictions in years of experience (median 10 (interquartile range (IQR) 15) years) or characteristics of the rehabilitation centre in which they were active. None of the participants had any experience with the use of the EXPERT tool at the time of patient case fill-out, to allow comparisons with EXPERT tool exercise prescriptions.
Patient cases
The five patient cases that were presented to the clinicians are summarized in Table 1 . In these cases, a gradual increase in level of complexity was built in (case 1 was the easiest, case 5 was the most difficult) by increasing the number of CVD risk factors or co-morbidities. Most clinicians filled out their exercise prescriptions online (via the EXPERT tool); others filled out the same patient cases on paper. All participants received exactly the same written instructions (in a manual) explaining how to fill out these patient cases: participants prescribing exercise online had freetext fields, whereas participants using paper had the corresponding space for writing. The clinicians were requested to specify exercise intensity (based on percentage of peak heart rate (HR peak )), exercise frequency (days/week), programme duration (weeks), exercise session duration (min/session) and whether strength training exercises should be executed. From these data, total exercise volume was calculated by number of prescribed weeks * number of prescribed sessions/week * prescribed individual session duration (min) * prescribed exercise intensity (%HR peak ) and expressed as peak-effort training hours. In addition, clinicians were requested to indicate whether other exercise training types, in addition to endurance or strength training, should be considered. These included, but were not restricted to, handgrip strength training, inspiratory muscle training, calisthenics and balance exercises.
EXPERT tool recommendations
In the EXPERT tool, exercise training recommendations and safety precautions are available for ten CVDs, five CVD risk factors and three common chronic non-CV conditions. The EXPERT tool also considers baseline exercise tolerance, common CV medications and occurrence of adverse events during exercise testing. 18, 19 This tool is a training and decision support system, designed and built by computer scientists from the Expertise Centre of Digital Media of Hasselt University, in close collaboration with the EAPC EXPERT working group. It automatically provides an exercise prescription according to the characteristics of each patient case, thus integrating different exercise prescriptions for different CVDs and risk factors for the same patient. The exercise prescriptions of the EXPERT tool are based on clinical guidelines, 5-8 evidence and expert opinions, which were collected by a working group of 33 CV rehabilitation specialists from 11 European countries. 18, 19 This tool was used to generate exercise prescriptions for the five patient cases that were the subject of the present study. Medication intake: statin, ACEinhibitor, orlistat, antiplatelet, metformin, sulfonylurea.
Medication intake: statin, antiplatelet, beta-blocker, digitalis, mucolytics, bronchodilators.
Medication intake: beta-blocker, statin, exogenous insulin, nitrate, erythropoietin.
Medication intake: beta-blocker, bronchodilator, antiplatelet.
(continued) Additional isometric handgrip exercise training is advised.
Additional isometric handgrip exercise training is advised.
>900
kcal/week of energy expenditure should be achieved.
Muscle electrostimulation, balance training, or tai chi may be added.
Flexibility and balance exercises should be added.
Breathing exercises should be added.
HR, heart rate; PCI, percutaneous coronary intervention; ACE, angiotensin-converting-enzyme; AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; HIT, high-intensity training.
Statistical analyses
Statistical analyses were performed using SPSS v.24.0 (SPSS Inc., Chicago, USA). According to the ShapiroWilk and Kolmogorov-Smirnov tests, the exercise prescription data generated by the clinicians were not normally distributed. Therefore, the data are presented as median (IQR). First, the variance in exercise prescription between clinicians was calculated for each case separately, and the Kruskal-Wallis test was used to further examine whether exercise prescriptions were different between patient cases. Second, Friedman and chisquare tests were used to compare exercise prescriptions generated by the clinicians with those generated by the EXPERT tool. Third, linear multivariate regression analyses and binary logistic regression analyses were applied to study relationships between clinician characteristics (occupation type, years of experience and country) and exercise prescriptions. In these models, parameters with non-normal distributions were first log-transformed. Fourth, relationships between exercise parameters were analysed by univariate Spearman correlations. Statistical significance was set at p < 0.05 (two-tailed).
Results
Exercise prescriptions: inter-clinician comparisons
Exercise prescriptions for each patient case are displayed in Table 2 . The prescribed endurance exercise intensity, frequency, session duration, and the prescription rates of strength training were significantly different between patient cases (p < 0.05). The most intense and longest exercise sessions were prescribed for patient case 2 (leading to the greatest total exercise volume), whereas the least intense and shortest exercise sessions were prescribed for patient case 3. Strength training was most often prescribed for patient case 3 and least often for patient case 4. In addition, the variance in prescribed exercise intensity, frequency, session and programme duration, and total exercise volume was significantly different between patient cases. The greatest variances in prescribed exercise intensity and frequency were observed in patient cases 5 and 3, respectively. The greatest variances in prescribed session/programme duration and total exercise volume were observed in patient cases 2 and 4, respectively. When combining all five patient cases, a large interclinician variance was found for exercise intensity (median (IQR) 83 (13) % of HR peak ), frequency (median (IQR) 4 (2) days/week), session duration (median (IQR) 45 (18) min/session), programme duration (median (IQR) 12 (18) weeks), total exercise volume (median (IQR) 1215 (1961) peak-effort training hours) and whether strength training was prescribed (this was prescribed in 78% of all cases) ( Figure 1 and Table 2 ).
Exercise prescriptions: correlations between exercise modalities
When analysing all patient cases (n ¼ 265), significant statistical correlations were found, although all these Comparisons between clinicians' exercise prescriptions and EXPERT tool exercise prescriptions Exercise prescriptions were significantly different between clinicians and the EXPERT tool (p < 0.001, Table 1 and 2), except for implementation of strength training (p > 0.10). Although many additional exercise/ training types could have been prescribed (such as handgrip strength training, inspiratory muscle strength training, balance exercises, etc.), clinicians proposed these in only 34 patient cases (out of 265). The additional exercise/training types prescribed included inspiratory muscle training, calisthenics, Nordic walking and flexibility exercises.
Discussion
This study, which was the first of its kind, showed that in Europe a large inter-clinician variance in exercise prescription for CVD patients and those at risk was present, even when generated by experienced CV rehabilitation specialists (median 10 years of experience). Moreover, exercise prescriptions generated by clinicians were significantly different from exercise recommendations generated by the EXPERT tool.
The observed large inter-clinician variance in exercise prescription for patients with different CVDs and risk factors could be related to different habits in exercise prescription, knowledge of clinical guidelines, and education and/or organization of the rehabilitation unit both in and between countries. 20 In addition, some national guidelines on exercise training in CVD are (slightly) different from international guidelines, 21, 22 which may also lead to inter-clinician variance in exercise prescriptions when clinicians from different countries are included. Most importantly, these different exercise prescriptions may also originate from the lack of guidelines on how to integrate different exercise prescriptions within the same patients with different CVDs and risk factors. As well as these hypothesized causes, different exercise prescription routines may also result from legal constraints (such as national regulations for reimbursement of rehabilitation sessions, which could affect programme duration and total number of exercise sessions) and environmental constraints (such as limited infrastructure and centre/hospital facilities, which may affect the capacity to implement strength training exercises or other exercise training types). For example, very long programmes (up to 40 weeks) are thought to significantly affect blood lipid profile; however, these may be unachievable by many rehabilitation centres/hospitals. 23 The inter-clinician variance was of unexpected magnitude for all exercise modalities: exercise intensity (median (IQR) 83 (13) % of HR peak ), frequency (median (IQR) 4 (2) days/week), session duration (median (IQR) 45 (18) min/session), total exercise volume (median (IQR) 1215 (1961) peak-effort training hours) and programme duration (median (IQR) 12 (18) weeks). Interestingly, these exercise prescriptions were further modulated by the clinician's country (for exercise intensity) and by their type of occupation and years of experience (for exercise programme duration and total exercise volume). Certain logical and expected relationships between exercise modalities (for example, a correlation between higher exercise intensity and shorter exercise session duration) were absent, and the observed significant relationships (p < 0.05) within this study were poor (r < 0.30). This may indicate that prescriptions of certain exercise modalities were not corrected for by (necessary) adaptations in other exercise modalities. As these exercise prescriptions were generated by experienced CV rehabilitation clinicians, an even greater inter-clinician variance may be expected among non-experts or less experienced colleagues.
The exercise prescriptions generated by clinicians were significantly different from those generated by the EXPERT tool (p < 0.001), except for the implementation of strength training and total exercise volume. This was unsurprising, as the EXPERT is new and had not yet been used by the study participants. However, this comparison shows which training modalities must be optimized during exercise prescription. Moreover, clinicians rarely prescribed other exercise training types (in addition to endurance or strength training), such as Nordic walking, calisthenics and inspiratory muscle strength training. Although the EXPERT tool cannot be guaranteed to provide a 'gold standard' exercise prescription, this instrument approaches exercise prescription as recommended in clinical guidelines and is based on expert opinions agreed upon in the working group consortium. As such, the EXPERT tool recommends exercise prescriptions according to state-of-the-art knowledge in CV rehabilitation.
These data indicate that standardization of exercise prescription in CV rehabilitation is warranted. Some factors influencing the variance in exercise prescription might be reversible, or might be directly related to the clinician's adherence to, or knowledge of, clinical guidelines. In addition, it seems very important to achieve agreement between different national exercise guidelines and international exercise recommendations. Moreover, the existing exercise guidelines do not specify how to integrate exercise prescriptions for different CVDs and risk factors within the same patient, making exercise prescription challenging in clinical practice. These factors are good candidates to be tackled in standardization efforts. Such standardization may then lead to optimization of the clinical benefits and medical safety of exercise intervention in CVD (risk). The EXPERT tool is such an instrument; it can assist in this endeavour by providing exercise prescriptions according to an integrated interpretation of published guidelines, especially in patients with different CVDs and risk factors, and by providing a training environment for novice clinicians. In other fields of medicine, such decision support systems have been shown to effectively increase the implementation of clinical guidelines in clinical practice. [24] [25] [26] [27] [28] In addition, it may be relevant to set up a performance measure assessment system for CV rehabilitation units. In addition to patient referral 29 and service delivery, 30 whether the prescribed exercises are in line with exercise guidelines could be a crucial performance measure, leading to quality improvement of CV rehabilitation throughout Europe. Such an initiative would be consistent with the strategic goals of the EAPC.
A large majority of patients at risk of CVD in Europe are prevented from achieving their lifestyle, blood pressure, lipid and glucose goals. 31 This may be owing to suboptimal prescription of cardioprotective medication (or a lack of adherence to these prescriptions), insufficient smoking cessation, or a low implementation rate of dietary interventions. Data from the present study suggest that suboptimal exercise prescription may also be present in routine clinical practice; this should be taken into account as a potential explanation for insufficient CVD risk factor control in Europe.
This study may have had some limitations. As the EAPC consists of >3000 members from >40 countries, data from the present study warrant confirmation from a larger survey throughout Europe. In addition, the study sample was too small to determine whether guideline adherence is different between different countries or age groups, whether educational background affects guideline adherence, or whether a similar interclinician variance in exercise prescriptions for CVD (risk) patients exists in other continents and in other healthcare professions that were underrepresented in the current survey. It may be questioned whether the participants were a representative sample of European CV exercise prescribers. All participants are actively involved in CV rehabilitation, and some are also actively involved in clinical studies within this field and/or are authors of important publications in the field of CV rehabilitation. As a result, data from the present study reflect the inter-clinician variance for exercise prescription in more experienced clinicians.
However, this variance remains to be studied in novice or less experienced clinicians.
In conclusion, there is a large inter-clinician variance in exercise prescription for CVD patients, and clinicians' exercise prescriptions are significantly different from those generated by the EXPERT tool. The present data confirm the importance of and justify the need for standardization efforts regarding integrated exercise prescription in CV rehabilitation.
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